PPIDT00028
Drug Information
| Name | Insulin human |
|---|---|
| Sequence | GIVEQCCTSICSLYQLENYCN |
| DrugBank_ID | DB00030 |
| Type | biotech |
| Indication | Human insulin is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Injection, suspension | Cutaneous; Parenteral |
100 IU/ml
|
| Injection, suspension | Cutaneous; Parenteral |
40 IU/ml
|
| Injection, suspension | Parenteral; Subcutaneous |
100 UI/ML
|
| Injection, suspension | Parenteral; Subcutaneous |
100 IU/ml
|
| Injection, suspension | Parenteral; Subcutaneous |
40 UI/ML
|
| Injection, suspension | Parenteral |
|
| Injection, solution | Intravenous; Parenteral |
100 IU/ML
|
| Injection, solution | Intravenous; Parenteral |
40 IU/ML
|
| Injection, solution | Intravenous; Subcutaneous |
100 IU/ML
|
| Injection, solution | Intravenous; Subcutaneous |
40 iu/ml
|
| Injection, solution | Parenteral; Subcutaneous |
100 IU/ML
|
| Solution | Subcutaneous |
|
| Injection, solution | Parenteral |
100 IU/mL
|
| Injection | — |
|
| Injection | Intramuscular; Intravenous; Subcutaneous |
100 IU/ml
|
| Injection, solution | Parenteral |
100 IE
|
| Injection, solution | Parenteral |
100 IE/ML
|
| Injection, solution | Parenteral |
100 I.E./ML
|
| Solution | Subcutaneous |
100 IU/ml
|
| Solution | — |
100 IU/ml
|
| Kit | Respiratory (inhalation) |
|
| Powder, metered | Respiratory (inhalation) |
12 [arb'U]/1
|
| Powder, metered | Respiratory (inhalation) |
4 [arb'U]/1
|
| Powder, metered | Respiratory (inhalation) |
5
|
| Powder, metered | Respiratory (inhalation) |
8 [arb'U]/1
|
| Powder, metered | Respiratory (inhalation) |
9
|
| Injection, suspension | Parenteral |
3 ML
|
| Injection, solution | Parenteral |
3 ML
|
| Injection, suspension | Subcutaneous |
|
| Injection, suspension | — |
100 iu/1ml
|
| Solution | Subcutaneous |
500 unit / mL
|
| Aerosol, powder | Respiratory (inhalation) |
1 mg/1
|
| Aerosol, powder | Respiratory (inhalation) |
3 mg/1
|
| Powder | Oral |
1 mg
|
| Solution | Parenteral |
100.00 UI
|
| Injection | Parenteral |
|
| Injection, solution | Subcutaneous |
|
| Injection, solution | — |
|
| Injection, suspension | Parenteral |
100 IU
|
| Injection, suspension | Parenteral |
1000 IU
|
| Injection, solution | Parenteral |
100 IU
|
| Injection, solution | Intravenous |
100 IU/ML
|
| Injection, solution | Subcutaneous |
100 IU/ML
|
| Injection, suspension | Subcutaneous |
100 units/mL
|
| Injection, suspension | Subcutaneous |
40 units/mL
|
| Suspension | Subcutaneous |
|
| Injection | Subcutaneous |
100 U/ML
|
| Injection | Intramuscular; Subcutaneous |
|
| Injection, suspension | — |
100 IU
|
| Injection, suspension | Subcutaneous |
100 [iU]/1mL
|
| Injection, suspension | Subcutaneous |
100
|
| Injection, suspension | Parenteral |
300 IU
|
| Injection | Subcutaneous |
|
| Suspension | Subcutaneous |
100 unit/mL
|
| Suspension | Subcutaneous |
100 unit / mL
|
| Injection | Intramuscular; Subcutaneous |
100 iu/ml
|
| Injection, solution | Parenteral |
300 IU
|
| Injection, solution | — |
100 IU
|
| Injection, solution | Parenteral |
100 [iU]/1mL
|
| Injection, solution | Subcutaneous |
100 [iU]/1mL
|
| Solution | Intramuscular; Intravenous; Subcutaneous |
100 unit/mL
|
| Solution | Subcutaneous |
100 UI
|
| Solution | Intramuscular; Subcutaneous |
100 unit/mL
|
| Injection, solution | Subcutaneous |
500 [iU]/1mL
|
| Injection, solution | Intravenous |
1 IU/ml
|
| Injection, solution | Intravenous |
1 UI/mL
|
| Solution | — |
100 UI
|
| Injection, suspension | Subcutaneous |
100 IU/mL
|
| Suspension | Subcutaneous |
|
| Injection | — |
100 iu/ml
|
| Injection, suspension | Parenteral |
100 IE/ML
|
| Injection | Subcutaneous |
100 IU/ml
|
| Injection, suspension | Subcutaneous |
30 iu/1mL
|
| Suspension | Intramuscular; Subcutaneous |
10000000 IU
|
| Solution | Subcutaneous |
10000000 IU
|
| Solution | Parenteral |
100.000 UI
|
| Injection, solution | Intramuscular; Parenteral |
100 IU/ML
|
| Injection, solution | Intravenous; Parenteral |
100 UI/ML
|
| Injection, solution | Parenteral; Subcutaneous |
100 UI/ML
|
| Injection, solution | Parenteral; Subcutaneous |
40 UI/ML
|
| Injection, suspension | Intramuscular |
100 IU/ml
|
| Injection, suspension | Intramuscular |
40 IU/ml
|
| Injection, suspension | Intramuscular; Subcutaneous |
100 IU/ml
|
| Injection, suspension | Subcutaneous |
100 UI/ML
|
| Injection, suspension | Subcutaneous |
40 UI/ML
|
| Injection, suspension | Subcutaneous |
40 IU/ml
|
| Solution | Subcutaneous |
100 UI/ML
|
| Solution | Subcutaneous |
40 UI/ML
|
| Suspension | — |
100 IU/ML
|
| Injection, suspension | Parenteral |
100 I.E./ML
|
| Injection, suspension | Parenteral |
40 IE/ML
|
| Injection, suspension | Parenteral |
100 IE
|
| Suspension | Subcutaneous |
100 IU/ml
|
| Injection, solution | Intraperitoneal |
400 IU/ml
|
| Injection, solution | Parenteral |
40 IE/ML
|
| Injection, solution | — |
100 iu/ml
|
| Injection; injection, solution | — |
100 IU/ml
|
| Injection | — |
300 IU/ml
|
| — | Subcutaneous |
100 unit / mL
|
| Injection | Subcutaneous |
|
| Injection | Subcutaneous |
70 IU/ml
|
| Injection, suspension | Parenteral |
100 IU/ml
|
| Injection, suspension | Subcutaneous |
|
| Injection, solution | Intravenous |
1.00 [iU]/1mL
|
| Solution | Intravenous |
1 unit / mL
|
| Injection, suspension | Subcutaneous |
100 [USP'U]/1mL
|
| Suspension | Subcutaneous |
100 UI
|
| Solution | Intramuscular; Intravenous; Subcutaneous |
100 unit / mL
|
| Solution | Other |
100 UI
|
| Solution | Intravenous; Subcutaneous |
10000000 IU
|
| Liquid | Intramuscular; Intravenous; Subcutaneous |
100 unit / mL
|
| Injection, suspension | Parenteral; Subcutaneous |
40 IU/ML
|
| Injection, suspension | Parenteral |
100 UI/ml
|
| Injection | — |
100 IU
|
| Suspension | — |
|
| Solution | Intramuscular; Intravenous; Subcutaneous |
10000000 IU
|
| Suspension | Subcutaneous |
10000000 IU
|
| Solution | Parenteral |
100 UI
|
| Suspension | Parenteral |
100 UI
|
| Injection, suspension | — |
|
| Suspension | — |
|
| Suspension | — |
100 iu/1ml
|
| Injection, solution | — |
100 iu/1ml
|
| Solution | — |
100 iu/1ml
|
Target Information
| Role | Uniprot_ID | Gene_Name | Entity_Name | Organism | Actions | Internal link |
|---|---|---|---|---|---|---|
| target | P06213 | INSR | Insulin receptor | Homo sapiens | agonist | Link |
| target | P08069 | IGF1R | Insulin-like growth factor 1 receptor | Homo sapiens | activator | Link |
| target | P16870 | CPE | Carboxypeptidase E | Homo sapiens | modulator|product of | Link |
| target | P48745 | CCN3 | CCN family member 3 | Homo sapiens | downregulator | Link |
| target | P98164 | LRP2 | Low-density lipoprotein receptor-related protein 2 | Homo sapiens | substrate | Link |
| target | Q16270 | IGFBP7 | Insulin-like growth factor-binding protein 7 | Homo sapiens | inhibitor|binder | Link |
| enzyme | P14735 | IDE | Insulin-degrading enzyme | Homo sapiens | substrate|cleavage | Link |
| enzyme | P16519 | PCSK2 | Neuroendocrine convertase 2 | Homo sapiens | activator | Link |
| enzyme | P29120 | PCSK1 | Neuroendocrine convertase 1 | Homo sapiens | activator | Link |
| enzyme | P05177 | CYP1A2 | Cytochrome P450 1A2 | Homo sapiens | inducer | Link |